Division of Breast Surgery, National Cancer Center Hospital, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.
Breast Cancer. 2010 Apr;17(2):92-6. doi: 10.1007/s12282-009-0166-0. Epub 2009 Sep 30.
Recent progress in biotechnology, notably microarray analyses, makes it possible to examine the genome-based characteristics of tumors with different prognoses and predict responses to chemotherapy. Furthermore, pharmacogenomic techniques are expected to predict the optimal regimen for individual patients that will provide high benefits with reduced toxicity. Some predictive or prognostic tests for breast cancer are now moving from bench to bedside.
生物技术的最新进展，特别是微阵列分析，使得研究不同预后肿瘤的基因组特征和预测化疗反应成为可能。此外，药物基因组学技术有望预测每个患者的最佳治疗方案，以降低毒性并提高疗效。一些用于乳腺癌的预测或预后检测正从实验室走向临床。
